American Regent, Inc. recalls niCARdipine Hydrochloride Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
- Products
-
- niCARdipine Hydrochloride Injection
- Company
- American Regent, Inc.
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 7,249 (cartons of 10 x 10 mL vials)
- About this recall
- niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]